Talzenna .25 mg/1

Talzenna .25 mg/1 is a medication used to treat certain types of cancer. This oral capsule, manufactured by Pfizer, contains the active ingredient talazoparib. Learn more about its uses and effects.

Talzenna .25 mg/1 is primarily used in the treatment of specific cancers. It works by targeting certain proteins involved in cancer cell growth. Talazoparib, the active ingredient, is often prescribed for conditions where other treatments may not be effective. Patients and healthcare providers may explore its use for various types of cancer, including those that are hereditary.

Common effects of Talzenna .25 mg/1 may include fatigue, nausea, and anemia. Some users might experience changes in taste or appetite. It's important to discuss any persistent or severe effects with a healthcare professional. The medication's impact can vary depending on individual health factors.

Talzenna .25 mg/1 should be handled with care. It is essential to follow the prescribed dosage and administration instructions. Patients with certain medical conditions or allergies should inform their healthcare provider before starting this medication. Proper storage and disposal of the capsules are also important to ensure safety.

Talzenna .25 mg/1 may interact with other medications, including those that affect liver enzymes. Alcohol and certain supplements might also influence its effectiveness. It's crucial to discuss all current medications and supplements with a healthcare provider to avoid potential interactions. Always consult a professional before making any changes to your medication regimen.